← All MEPs

Colm Markey

European Parliament · 🇮🇪 Ireland · former MEP

Term: from 24 November 2020 to 25 April 2024

Participation in roll-call votes

95 % of the 1,587 roll-call votes held during their term: took part in the vote (for, against or abstention)

Participation month by month

0 % 50 % 100 % November 2020 : participation 100 % (23 / 23), presence 100 % (23 / 23) 2020 December 2020 : participation 100 % (30 / 30), presence 100 % (30 / 30) January 2021 : participation 100 % (23 / 23), presence 100 % (23 / 23) 2021 February 2021 : participation 100 % (21 / 21), presence 100 % (21 / 21) March 2021 : participation 100 % (31 / 31), presence 100 % (31 / 31) April 2021 : participation 100 % (81 / 81), presence 100 % (81 / 81) May 2021 : participation 100 % (26 / 26), presence 100 % (26 / 26) June 2021 : participation 100 % (29 / 29), presence 100 % (29 / 29) July 2021 : participation 70 % (19 / 27), presence 70 % (19 / 27) September 2021 : participation 100 % (19 / 19), presence 100 % (19 / 19) October 2021 : participation 100 % (42 / 42), presence 100 % (42 / 42) November 2021 : participation 100 % (27 / 27), presence 100 % (27 / 27) December 2021 : participation 72 % (21 / 29), presence 72 % (21 / 29) January 2022 : participation 100 % (7 / 7), presence 100 % (7 / 7) 2022 February 2022 : participation 100 % (29 / 29), presence 100 % (29 / 29) March 2022 : participation 100 % (37 / 37), presence 100 % (37 / 37) April 2022 : participation 100 % (22 / 22), presence 100 % (22 / 22) May 2022 : participation 97 % (85 / 88), presence 97 % (85 / 88) June 2022 : participation 100 % (46 / 46), presence 100 % (46 / 46) July 2022 : participation 100 % (31 / 31), presence 100 % (31 / 31) September 2022 : participation 100 % (25 / 25), presence 100 % (25 / 25) October 2022 : participation 100 % (32 / 32), presence 100 % (32 / 32) November 2022 : participation 97 % (37 / 38), presence 97 % (37 / 38) December 2022 : participation 94 % (17 / 18), presence 94 % (17 / 18) January 2023 : participation 100 % (16 / 16), presence 100 % (16 / 16) 2023 February 2023 : participation 100 % (29 / 29), presence 100 % (29 / 29) March 2023 : participation 100 % (29 / 29), presence 100 % (29 / 29) April 2023 : participation 100 % (24 / 24), presence 100 % (24 / 24) May 2023 : participation 99 % (92 / 93), presence 99 % (92 / 93) June 2023 : participation 98 % (39 / 40), presence 98 % (39 / 40) July 2023 : participation 95 % (38 / 40), presence 95 % (38 / 40) September 2023 : participation 85 % (23 / 27), presence 85 % (23 / 27) October 2023 : participation 98 % (39 / 40), presence 98 % (39 / 40) November 2023 : participation 68 % (36 / 53), presence 68 % (36 / 53) December 2023 : participation 95 % (38 / 40), presence 95 % (38 / 40) January 2024 : participation 98 % (48 / 49), presence 98 % (48 / 49) 2024 February 2024 : participation 70 % (44 / 63), presence 70 % (44 / 63) March 2024 : participation 100 % (50 / 50), presence 100 % (50 / 50) April 2024 : participation 99 % (210 / 213), presence 99 % (210 / 213)

Their votes

1,587 votes

DateTextResultTheir vote
Implementation of EU requirements for exchange of tax information For
The situation in Kakuma refugee camp in Kenya For
The case of human rights defender Ahmed Mansoor in UAE Abstention
Government crackdown on protests and citizens in Cuba For
Identifying gender-based violence as a new area of crime listed in Article 83(1) TFEU For
Serious cross-border threats to health For
European Centre for Disease Prevention and Control For
Fair working conditions, rights and social protection for platform workers - New forms of employment linked to digital development For
Guidelines for the employment policies of the Member States For
A new EU-China strategy For
Criteria for the designation of antimicrobials to be reserved for the treatment of certain infections in humans Against
Extension of validity of safety certificates and licences of railway undertakings operating in the Channel tunnel For
Official controls on animals and products of animal origin in order to ensure compliance with the prohibition of certain uses of antimicrobials For
EU Blue Card Directive For
Brexit Adjustment Reserve For
Community plant variety rights: extension of the term for certain varieties For
Union environment action programme (2021-2030) For
European Medicines Agency For
A new ERA for Research and Innovation For
Breaches of EU law and of the rights of LGBTIQ citizens in Hungary as a result of the legal changes adopted by the Hungarian Parliament Absent
The establishment of Antarctic Marine Protected Areas (MPAs) and the conservation of Southern Ocean biodiversity Absent
The repression of the opposition in Turkey, specifically the Peoples’ Democratic Party (HDP) Absent
The situation in Nicaragua Absent
The death penalty in Saudi Arabia, notably the cases of Mustafa Hashem al-Darwish and Abdullah al-Howaiti Absent
Hong Kong, notably the case of Apple Daily Absent
The case of Ahmadreza Djalali in Iran Absent
Decision on the numerical strength of the special committees and the committee of inquiry Absent
Annual Report on the functioning of the Schengen area For
EU global human rights sanctions regime (EU Magnitsky Act) For
The creation of guidelines for the application of the general regime of conditionality for the protection of the Union budget For
Old continent growing older - possibilities and challenges related to ageing policy post 2020 For
EU-NATO cooperation in the context of transatlantic relations Abstention
Citizens’ dialogues and Citizens’ participation in the EU decision-making For
Objection pursuant to Rule 112(2) and (3): Genetically modified maize Bt 11 (SYN-BTØ11-1) Against
The impact on the fishing sector of offshore windfarms and other renewable energy systems For
Protection of the EU’s financial interests - combatting fraud - annual report 2019 For
Objection pursuant to Rule 112(2) and (3): Genetically modified maize 1507 × MIR162 × MON810 × NK603 and genetically modified maize combining two or three of the single events 1507, MIR162, MON810 and NK603 Against
Objection pursuant to Rule 112(2) and (3): Genetically modified soybean DAS-81419-2 × DAS-44406–6 Against
Objection pursuant to Rule 112(2) and (3): Genetically modified soybean DAS-81419-2 Against
Control of the financial activities of the European Investment Bank - annual report 2019 Abstention

Rows per page: 20 40 100 200 All